The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Lupus Erythematosus, Systemic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lupus Erythematosus, Systemic


High impact information on Lupus Erythematosus, Systemic


Chemical compound and disease context of Lupus Erythematosus, Systemic


Biological context of Lupus Erythematosus, Systemic


Anatomical context of Lupus Erythematosus, Systemic


Gene context of Lupus Erythematosus, Systemic


Analytical, diagnostic and therapeutic context of Lupus Erythematosus, Systemic


  1. Ig heavy chain variable region gene complex of lupus mice exhibits normal restriction fragment length polymorphism. Kofler, R., Perlmutter, R.M., Noonan, D.J., Dixon, F.J., Theofilopoulos, A.N. J. Exp. Med. (1985) [Pubmed]
  2. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. Rolink, A.G., Pals, S.T., Gleichmann, E. J. Exp. Med. (1983) [Pubmed]
  3. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. Trouw, L.A., Groeneveld, T.W., Seelen, M.A., Duijs, J.M., Bajema, I.M., Prins, F.A., Kishore, U., Salant, D.J., Verbeek, J.S., van Kooten, C., Daha, M.R. J. Clin. Invest. (2004) [Pubmed]
  4. The Yaa gene abrogates the major histocompatibility complex association of murine lupus in (NZB x BXSB)F1 hybrid mice. Merino, R., Iwamoto, M., Gershwin, M.E., Izui, S. J. Clin. Invest. (1994) [Pubmed]
  5. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. Akilesh, S., Shaffer, D.J., Roopenian, D. Genome Res. (2003) [Pubmed]
  6. The site and stage of anti-DNA B-cell deletion. Chen, C., Nagy, Z., Radic, M.Z., Hardy, R.R., Huszar, D., Camper, S.A., Weigert, M. Nature (1995) [Pubmed]
  7. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Boackle, S.A., Holers, V.M., Chen, X., Szakonyi, G., Karp, D.R., Wakeland, E.K., Morel, L. Immunity (2001) [Pubmed]
  8. Renal papillary necrosis and pyelonephritis accompanying fenoprofen therapy. Husserl, F.E., Lange, R.K., Kantrow, C.M. JAMA (1979) [Pubmed]
  9. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. Boulé, M.W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A., Rifkin, I.R. J. Exp. Med. (2004) [Pubmed]
  10. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. Bolland, S., Yim, Y.S., Tus, K., Wakeland, E.K., Ravetch, J.V. J. Exp. Med. (2002) [Pubmed]
  11. Selective suppression of retroviral gp70-anti-gp70 immune complex formation by prostaglandin E1 in murine systemic lupus erythematosus. Izui, S., Kelley, V.E., McConahey, P.J., Dixon, F.J. J. Exp. Med. (1980) [Pubmed]
  12. Bromocriptine restores tolerance in estrogen-treated mice. Peeva, E., Grimaldi, C., Spatz, L., Diamond, B. J. Clin. Invest. (2000) [Pubmed]
  13. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. Schiffer, L., Sinha, J., Wang, X., Huang, W., von Gersdorff, G., Schiffer, M., Madaio, M.P., Davidson, A., Von Gonsdorff, G. J. Immunol. (2003) [Pubmed]
  14. Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Naparstek, Y., Ben-Yehuda, A., Madaio, M.P., Bar-Tana, R., Schuger, L., Pizov, G., Neeman, Z.V., Cohen, I.R. Arthritis Rheum. (1990) [Pubmed]
  15. Complement C4 is protective for lupus disease independent of C3. Einav, S., Pozdnyakova, O.O., Ma, M., Carroll, M.C. J. Immunol. (2002) [Pubmed]
  16. Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor. Fulpius, T., Spertini, F., Reininger, L., Izui, S. Proc. Natl. Acad. Sci. U.S.A. (1993) [Pubmed]
  17. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice. Wellmann, U., Letz, M., Schneider, A., Amann, K., Winkler, T.H. Int. Immunol. (2001) [Pubmed]
  18. Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Yurino, H., Ishikawa, S., Sato, T., Akadegawa, K., Ito, T., Ueha, S., Inadera, H., Matsushima, K. Toxicol. Sci. (2004) [Pubmed]
  19. Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice. Oates, J.C., Gilkeson, G.S. J. Investig. Med. (2004) [Pubmed]
  20. Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies. Chicheportiche, Y., Fossati-Jimack, L., Moll, S., Ibnou-Zekri, N., Izui, S. Biochem. Biophys. Res. Commun. (2000) [Pubmed]
  21. The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseases. Hurd, E.R., Giuliano, V.J. Arthritis Rheum. (1975) [Pubmed]
  22. Cytokine dysregulation induced by apoptotic cells is a shared characteristic of macrophages from nonobese diabetic and systemic lupus erythematosus-prone mice. Fan, H., Longacre, A., Meng, F., Patel, V., Hsiao, K., Koh, J.S., Levine, J.S. J. Immunol. (2004) [Pubmed]
  23. Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus. Tsujimura, S., Saito, K., Nakayamada, S., Nakano, K., Tanaka, Y. Arthritis Rheum. (2005) [Pubmed]
  24. Quantitative trait locus analysis of plasma lipoprotein levels in an autoimmune mouse model : interactions between lipoprotein metabolism, autoimmune disease, and atherogenesis. Gu, L., Johnson, M.W., Lusis, A.J. Arterioscler. Thromb. Vasc. Biol. (1999) [Pubmed]
  25. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. Vogelweid, C.M., Johnson, G.C., Besch-Williford, C.L., Basler, J., Walker, S.E. J. Neuroimmunol. (1991) [Pubmed]
  26. Epistatic suppression of systemic lupus erythematosus: fine mapping of Sles1 to less than 1 mb. Subramanian, S., Yim, Y.S., Liu, K., Tus, K., Zhou, X.J., Wakeland, E.K. J. Immunol. (2005) [Pubmed]
  27. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. Mohan, C., Morel, L., Yang, P., Wakeland, E.K. J. Immunol. (1997) [Pubmed]
  28. Fas (CD95)-independent regulation of immune responses by antigen-specific CD4-CD8+ T cells. Teh, S.J., Dutz, J.P., Motyka, B., Teh, H.S. Int. Immunol. (1996) [Pubmed]
  29. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice. Zachrau, B., Finke, D., Kropf, K., Gosink, H.J., Kirchner, H., Goerg, S. Int. Immunol. (2004) [Pubmed]
  30. Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R). Schorlemmer, H.U., Dickneite, G., Kanzy, E.J., Enssle, K.H. Inflamm. Res. (1995) [Pubmed]
  31. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. Zhang, X.K., Gallant, S., Molano, I., Moussa, O.M., Ruiz, P., Spyropoulos, D.D., Watson, D.K., Gilkeson, G. J. Immunol. (2004) [Pubmed]
  32. Pulmonary inflammation in autoimmune MRL/Mp-lpr/lpr mice. Histopathology and bronchoalveolar lavage evaluation. Sunderrajan, E.V., McKenzie, W.N., Lieske, T.R., Kavanaugh, J.L., Braun, S.R., Walker, S.E. Am. J. Pathol. (1986) [Pubmed]
  33. Characterization of brain-reactive autoantibodies in murine models of systemic lupus erythematosus. Narendran, A., Hoffman, S.A. J. Neuroimmunol. (1989) [Pubmed]
  34. Gene therapy using non-viral peptide vector in a canine systemic lupus erythematosus model. Choi, E.W., Shin, I.S., Youn, H.Y., Kim, D.Y., Lee, H., Chae, Y.J., Lee, C.W. Vet. Immunol. Immunopathol. (2005) [Pubmed]
  35. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice. Lui, S.L., Tsang, R., Wong, D., Chan, K.W., Chan, T.M., Fung, P.C., Lai, K.N. Lupus (2002) [Pubmed]
WikiGenes - Universities